← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Harry S. Truman Memorial Va Hospital
Columbia, MO
$0
Total funding
39
Grants
Funding over time
peak $0 · FY2009–25$1$1$1$0$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
VA$0 · 39
By mechanism
I01$0 · 29
IK2$0 · 3
IK6$0 · 5
IS1$0 · 2
Investigators at Harry S. Truman Memorial Va Hospital
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
In Vivo Imaging of bcl-2 Expression in Lymphoma$0
I01 · FY2012 · VA
Targeted Radiotherapy/Chemotherapy Treatment of Prostate Cancer$0
I01 · FY2014 · VA
Optimizing anti-tumor immunity for maximal therapeutic efficacy in Colorectal Cancer$0
IK2 · FY2022 · VA
Role of Plasminogen Activator Inhibitor-1 in Vascular Smooth Muscle Cell Stiffening and Senescence$0
I01 · FY2022 · VA
Role of non-genomic regulation of mitochondrial trifunctional protein in NAFLD$0
I01 · FY2022 · VA
Mineralocorticoid Receptor-Mediated Vascular Insulin Resistance$0
IK2 · FY2015 · VA
Colon Cancer Chemoprevention and COX-2 Suppression by Ursodeoxycholic Acid$0
I01 · FY2015 · VA
Interactions of the RAAS and a Western Diet on Insulin Metabolic Actions$0
I01 · FY2013 · VA
Role of Fibrinolytic System in Vein Graft Remodeling$0
I01 · FY2013 · VA
Targeting the Endothelial Glycocalyx to Enhance Vascular Function and Exercise-Induced Vascular Adaptations in Type 2 Diabetes$0
I01 · FY2022 · VA
BLR&D Research Career Scientist Award Application (Renewal)$0
IK6 · FY2022 · VA
Interactions of the RAAS and a Western Diet on Insulin Metabolic Actions$0
I01 · FY2014 · VA
Targeted Gene Therapy and Nanomedicine Approaches to Treat Corneal Diseases$0
I01 · FY2017 · VA
Interactions of the RAAS and a Western Diet on Insulin Metabolic Actions$0
I01 · FY2015 · VA
Targeted Radiotherapy/Chemotherapy Treatment of Prostate Cancer$0
I01 · FY2015 · VA
GRPR/PSMA Targeting Agents for Prostate Cancer Diagnosis$0
I01 · FY2017 · VA
Endothelial Cell Mineralocorticoid Receptor and Tubulointerstitial Fibrosis$0
I01 · FY2017 · VA
Hepatic Mitochondria and Insulin Resistance in Fatty Liver and Type 2 Diabetes$0
IK2 · FY2015 · VA
TRAF3IP2 in Adverse Cardiac Remodeling and Heart Failure$0
I01 · FY2021 · VA
Targeted Gene Therapy and Nanomedicine Approaches to Treat Corneal Diseases$0
I01 · FY2015 · VA